Sandra Levy
ARTICLES BY THIS AUTHOR
- 6/22/2020
AAM weighs in on trade rep's USMCA testimony
AAM welcomed testimony in which U.S. Trade Representative Robert Lightizer said the free trade agreement currently being negotiated will not contain a provision requiring 10-years of biologic exclusivity. - 6/22/2020
Bausch + Lomb inks deal with Stada, Xbrane for Lucentis biosimilar candidate
Bausch + Lomb will be responsible for sales, marketing, and other commercialization efforts for biosimilar Lucentis, following regulatory approval in the United States and Canada. - 6/21/2020
5 industry orgs share best practices for signature-free Rx access
To minimize the spread of COVID-19, industry organizations issued a joint statement outlining best practices for pharmacies and PBMs to follow for documenting signature-free delivery or pickup of prescriptions. - 6/21/2020
Walgreens resumes immunizations with new safety measures
Walgreens is resuming immunization services ahead of flu season, with safety measures that adhere to new CDC guidelines. - 6/21/2020
Abbott gets FDA clearance for FreeStyle Libre 2
Abbott's FreeStyle Libre 2 continuous glucose monitoring system does not require fingersticks. - 6/21/2020
PQA launches ‘Medication Use Quality’ CE program
The Pharmacy Quality Alliance’s 15-hour CE certificate accredited program on medication safety is aimed at pharmacists, nurses and physicians. - 6/21/2020
CVS Health, American Lung Association kick off COVID-19 Action Initiative campaign
An in-store fundraising campaign to support the American Lung Association's COVID-19 Action Initiative will run at 9,900 CVS Pharmacy locations through July 18. - 6/18/2020
Merck acquires Themis
Merck’s acquisition of Themis is expected to accelerate the development of a measles vector-based SARS-CoV-2 vaccine candidate. - 6/18/2020
PQA's Cranston to step down as CEO
Pharmacy Quality Alliance CEO Laura Cranston will step down later this year once a successor has been identified. - 6/18/2020
Dr. Reddy's releases generic Zytiga
The Zytiga brand and generic had a market value of approximately $454 million for the most recent 12 months ended March 2020, according to IQVIA.
